David Ricks, CEO of Eli Lilly, discusses the development of therapies to treat COVID-19 with CNBC’s “Squawk on the Street” team and Bill George, a CNBC contributor and former Medtronic CEO.
This content was originally posted on CNBC.com on 3/30/20.
Terrific offer for my book, True North: Emerging Leader Edition on special sale for $3.99 for Kindle edition. Order Now
Mar 30, 2020
David Ricks, CEO of Eli Lilly, discusses the development of therapies to treat COVID-19 with CNBC’s “Squawk on the Street” team and Bill George, a CNBC contributor and former Medtronic CEO.
This content was originally posted on CNBC.com on 3/30/20.